K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort Study

被引:254
|
作者
Brink, M
de Goeij, AFPM
Weijenberg, MP
Roemen, GMJM
Lentjes, MHFM
Pachen, MMM
Smits, KM
de Bruïne, AP
Goldbohm, RA
van den Brandt, PA
机构
[1] Maastrict Univ, Dept Epidemiol, NUTRIM, NL-6200 MD Maastricht, Netherlands
[2] Maastrict Univ, Dept Pathol, GROW, Maastricht, Netherlands
[3] TNO Nutr & Food Res, NL-3700 AJ Zeist, Netherlands
关键词
D O I
10.1093/carcin/bgg009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Activation of K-ras oncogene has been implicated in colorectal carcinogenesis, being mutated in 30-60% of the adenocarcinomas. In this study, 737 incident colorectal cancer (CRC) patients, originating from 120 852 men and women (55-69 years at baseline) participating in the Netherlands Cohort Study (NLCS), were studied in order to evaluate subgroups with respect to K-ras mutation status. Mutation analysis of the exon 1 fragment of the K-ras oncogene, spanning codons 8-29, was performed on archival colorectal adenocarcinoma samples of all patients using macrodissection, nested PCR and direct sequencing of purified fragments. The method of mutation detection was validated by the confirmation of reported K-ras status in CRC cell lines, a good correlation between fresh-frozen and routinely fixed, paraffin-embedded tissue, a detection limit of 5% mutated DNA and a good reproducibility. Various types of K-ras mutations were evaluated with respect to tumour sub-localization, Dukes' stage and tumour differentiation. In 37% (271/737) of the patients, the exon 1 fragment of K-ras gene was found to be mutated. The predominant mutations are G>A transitions and G>T transversions, and codons 12 and 13 are the most frequently affected codons. Patients with a rectal tumour were found to have the highest frequency of G>T transversions as compared with patients with a colon or rectosigmoid tumour. This difference appeared to be confined to women with a rectal tumour harbouring G>T transversions. No significant differences were observed for Dukes' stage with respect to types of K-ras mutation, which does not support direct involvement of the K-ras oncogene in adenocarcinoma progression. The equal distribution of K-ras mutations among cases with or without a family history of colorectal cancer argues against an important role for this mutation in familial colorectal cancer, and could imply that K-ras mutations are more probably involved in environmental mechanisms of colorectal carcinogenesis.
引用
收藏
页码:703 / 710
页数:8
相关论文
共 50 条
  • [31] Concurrent mutations of K-ras oncogene at codons 12 and 22 in colon cancer
    Miyakura, Y
    Sugano, K
    Fukayama, N
    Konishi, F
    Nagai, H
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2002, 32 (06) : 219 - 221
  • [32] Role of K-ras mutations in colorectal carcinoma
    Chiang, JM
    CANCER LETTERS, 1998, 126 (02) : 179 - 185
  • [33] Concurrent mutation in exons 1 and 2 of the K-ras oncogene in colorectal cancer
    Palmirotta, Raffaele
    Savonarola, Annalisa
    Ludovici, Giorgia
    De Marchis, Maria Laura
    Covello, Renato
    Ettorre, Giuseppe Maria
    Ialongo, Cristiano
    Guadagni, Fiorella
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2011, 49 (04) : 729 - 733
  • [34] K-RAS ONCOGENE IN LUNG-CANCER
    AYMON, P
    CANCER JOURNAL - FRANCE, 1991, 4 (03): : 154 - 154
  • [35] Activating K-Ras mutations outwith ‘hotspot’ codons in sporadic colorectal tumours – implications for personalised cancer medicine
    G Smith
    R Bounds
    H Wolf
    R J C Steele
    F A Carey
    C R Wolf
    British Journal of Cancer, 2010, 102 : 693 - 703
  • [36] Clinical relevance of the K-ras oncogene in colorectal cancer: Experience in a Mexican population
    Cabrera-Mendoza, F.
    Gainza-Lagunes, S.
    Castaneda-Andrade, I.
    Castro-Zarate, A.
    REVISTA DE GASTROENTEROLOGIA DE MEXICO, 2014, 79 (03): : 166 - 170
  • [37] EGFR OVER-EXPRESSION AND K-RAS ONCOGENE MUTATION IN COLORECTAL CANCER
    Kim, H. J.
    Kim, H. S.
    Lee, S. C.
    Lee, I. K.
    Jung, C. K.
    Kang, W. K.
    Cho, H. M.
    Oh, S. T.
    ANNALS OF ONCOLOGY, 2010, 21 : I38 - I38
  • [38] Activating K-Ras mutations outwith 'hotspot' codons in sporadic colorectal tumours - implications for personalised cancer medicine
    Smith, G.
    Bounds, R.
    Wolf, H.
    Steele, R. J. C.
    Carey, F. A.
    Wolf, C. R.
    BRITISH JOURNAL OF CANCER, 2010, 102 (04) : 693 - 703
  • [39] The Frequency and Type of K-RAS Mutations in Mexican Patients With Colorectal Cancer: A National Study
    Cardenas-Ramos, Susana G.
    Alcazar-Gonzalez, Gregorio
    Reyes-Cortes, Luisa M.
    Torres-Grimaldo, Abdiel A.
    Calderon-Garciduenas, Ana L.
    Morales-Casas, Jose
    Flores-Sanchez, Patricia
    De Leon-Escobedo, Raul
    Gomez-Diaz, Antonio
    Moreno-Bringas, Carmen
    Sanchez-Guillen, Jorge
    Ramos-Salazar, Pedro
    Gonzalez-de Leon, Cesar
    Barrera-Saldana, Hugo A.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2017, 40 (03): : 274 - 276
  • [40] Detection of APC and k-ras mutations in the serum of patients with colorectal cancer
    Lauschke, H
    Caspari, R
    Friedl, W
    Schwarz, B
    Mathiak, M
    Propping, P
    Hirner, A
    CANCER DETECTION AND PREVENTION, 2001, 25 (01): : 55 - 61